MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, DMIIU has $509,725,411 in assets. $18,166,285 in debts.

Balance Sheets Overview

Current Ratio
52.79%
Quick Ratio
52.79%
Debt to Asset Ratio
3.56%
Unit: Dollar
Assets Breakdown
    • Cash and investments held in tru...
    • Cash
    • Prepaid expenses
Liabilities Breakdown
    • Ordinary shares subject to possi...
    • Accumulated deficit
    • Deferred underwriting fee payabl...
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
Cash
-223 315,087
Due from sponsor-Sponsor
--566,269
Cash
347,720 --
Prepaid expenses
4,041 25,814 15,000
Total current assets
351,761 26,037 896,356
Cash and investments held in trust account
509,373,650 504,933,800 500,109,355
Total non-current assets
509,373,650 504,933,800 -
Total assets
509,725,411 504,959,837 501,005,711
Accounts payable
49,166 99,359 4,592
Accrued expenses
53,957 88,343 5,843
Accrued offering costs
113,162 113,162 113,162
Over-allotment liability
--553,748
Promissory notes
450,000 --
Total current liabilities
666,285 300,864 677,345
Deferred underwriting fee payable
17,500,000 17,500,000 17,500,000
Total non-current liabilities
17,500,000 17,500,000 -
Total liabilities
18,166,285 17,800,864 18,177,345
Ordinary shares subject to possible redemption, 50,000,000 shares at redemption value of 10.19 and 10.10 per share as of march 31, 2026 and december 31, 2025, respectively
509,373,650 504,933,800 500,109,355
Ordinary shares, 0.0001 par value 220,000,000 shares authorized 13,700,000 shares issued and outstanding, excluding 50,000,000 shares subject to redemption as of march 31, 2026 and december 31, 2025
1,369 1,369 1,557
Accumulated deficit
-17,815,893 -17,776,196 -17,282,546
Total shareholders deficit
-17,814,524 -17,774,827 -17,280,989
Total liabilities, ordinary shares subject to possible redemption, and shareholders deficit
509,725,411 504,959,837 501,005,711
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and investmentsheld in trust account$509,373,650 Cash$347,720 Prepaid expenses$4,041 Total non-currentassets$509,373,650 Total current assets$351,761 Total assets$509,725,411 Accumulated deficit-$17,815,893 Total liabilities,ordinary shares subject...$509,725,411 Total shareholdersdeficit-$17,814,524 Ordinary shares, 0.0001par value...$1,369 Ordinary shares subjectto possible...$509,373,650 Total liabilities$18,166,285 Total non-currentliabilities$17,500,000 Total currentliabilities$666,285 Deferred underwritingfee payable$17,500,000 Promissory notes$450,000 Accrued offering costs$113,162 Accrued expenses$53,957 Accounts payable$49,166

Drugs Made In America Acquisition II Corp. (DMIIU)

Drugs Made In America Acquisition II Corp. (DMIIU)